NCT01459653 · BASELINE
Baseline characteristics
Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.
- denoms
- counts
- group Id
- BG000
- value
- 1447
- units
- Participants
- groups
- description
- Cancer patients treated with chemotherapy and who are prescribed commercially available filgrastim biosimilar for primary or secondary prophylaxis for FN. Only patients who had no major protocol violations and have a minimum of enrollment cycle and either one follow-up cycle or study end data with valid outcome data (i.e., ANC or completed CIN/FN data) belong to the evaluable sample and are analyzed.
- id
- BG000
- title
- EP2006, Evaluable Sample
- measures
- classes
- categories
- measurements
- group Id
- BG000
- spread
- 11.8
- value
- 61.3
- dispersion Type
- STANDARD_DEVIATION
- param Type
- MEAN
- title
- Age, Continuous
- unit Of Measure
- years
- classes
- categories
- measurements
- group Id
- BG000
- value
- 886
- title
- Female
- measurements
- group Id
- BG000
- value
- 561
- title
- Male
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Sex: Female, Male
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 1042
- title
- Caucasian
- categories
- measurements
- group Id
- BG000
- value
- 7
- title
- African
- categories
- measurements
- group Id
- BG000
- value
- 2
- title
- Asian
- categories
- measurements
- group Id
- BG000
- value
- 1
- title
- Other
- categories
- measurements
- group Id
- BG000
- value
- 395
- title
- Missing
- param Type
- NUMBER
- title
- Race/Ethnicity, Customized
- unit Of Measure
- participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 395
- title
- France
- categories
- measurements
- group Id
- BG000
- value
- 143
- title
- Hungary
- categories
- measurements
- group Id
- BG000
- value
- 50
- title
- Czech Republic
- categories
- measurements
- group Id
- BG000
- value
- 116
- title
- Spain
- categories
- measurements
- group Id
- BG000
- value
- 286
- title
- Poland
- categories
- measurements
- group Id
- BG000
- value
- 3
- title
- Belgium
- categories
- measurements
- group Id
- BG000
- value
- 64
- title
- Romania
- categories
- measurements
- group Id
- BG000
- value
- 27
- title
- Austria
- categories
- measurements
- group Id
- BG000
- value
- 145
- title
- Germany
- categories
- measurements
- group Id
- BG000
- value
- 32
- title
- United Kingdom
- categories
- measurements
- group Id
- BG000
- value
- 11
- title
- Switzerland
- categories
- measurements
- group Id
- BG000
- value
- 175
- title
- Italy
- param Type
- NUMBER
- title
- Region of Enrollment
- unit Of Measure
- participants
- classes
- categories
- measurements
- group Id
- BG000
- spread
- 8.5
- value
- 165.6
- description
- Number of participants analyzed: 1358
- dispersion Type
- STANDARD_DEVIATION
- param Type
- MEAN
- title
- Height
- unit Of Measure
- cm
- classes
- categories
- measurements
- group Id
- BG000
- spread
- 15.0
- value
- 72.1
- description
- Number of participants analyzed: 1357
- dispersion Type
- STANDARD_DEVIATION
- param Type
- MEAN
- title
- Weight
- unit Of Measure
- kg
- classes
- categories
- measurements
- group Id
- BG000
- spread
- 5.0
- value
- 26.3
- description
- Number of participants analyzed: 1354
- dispersion Type
- STANDARD_DEVIATION
- param Type
- MEAN
- title
- Body-Mass Index (BMI)
- unit Of Measure
- kg/m^2
- classes
- categories
- measurements
- group Id
- BG000
- value
- 116
- title
- Bone pain
- categories
- measurements
- group Id
- BG000
- value
- 78
- title
- Joint pain
- categories
- measurements
- group Id
- BG000
- value
- 31
- title
- Muscle pain
- categories
- measurements
- group Id
- BG000
- value
- 28
- title
- Headache
- categories
- measurements
- group Id
- BG000
- value
- 8
- title
- Epistaxis
- categories
- measurements
- group Id
- BG000
- value
- 7
- title
- GI bleeding
- categories
- measurements
- group Id
- BG000
- value
- 1
- title
- Skin hemorrhage
- description
- Medical history for each patient was recorded. A patient can fall into more than one or none of the categories displayed.
- param Type
- NUMBER
- title
- Medical history
- unit Of Measure
- participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 458
- title
- Hypertension
- categories
- measurements
- group Id
- BG000
- value
- 138
- title
- Anemia
- categories
- measurements
- group Id
- BG000
- value
- 122
- title
- Diabetes Type II
- categories
- measurements
- group Id
- BG000
- value
- 93
- title
- Coronary disease
- categories
- measurements
- group Id
- BG000
- value
- 90
- title
- Allergies
- categories
- measurements
- group Id
- BG000
- value
- 86
- title
- COPD
- description
- Comorbidities for each patient were recorded. Only those comorbidities with a relative frequency of 5% or more are displayed in the table. A patient can fall into more than one or none of the categories displayed.
- param Type
- NUMBER
- title
- Comorbidities
- unit Of Measure
- participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 35
- title
- History of any repeated infection
- categories
- measurements
- group Id
- BG000
- value
- 8
- title
- Type of repeated infection (chronic)
- categories
- measurements
- group Id
- BG000
- value
- 27
- title
- Type of repeated infection (recurrent, acute)
- categories
- measurements
- group Id
- BG000
- value
- 15
- title
- 1 infectious episode in past 3 months
- categories
- measurements
- group Id
- BG000
- value
- 7
- title
- 2 infectious episodes in past 3 months
- categories
- measurements
- group Id
- BG000
- value
- 3
- title
- 3 or more infectious episodes in past 3 months
- description
- History of repeated infections for each patient was recoded. A patient can fall into more than one or none of the categories displayed.
- param Type
- NUMBER
- title
- History of repeated infections
- unit Of Measure
- participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 466
- title
- Breast
- categories
- measurements
- group Id
- BG000
- value
- 345
- title
- Lung
- categories
- measurements
- group Id
- BG000
- value
- 245
- title
- Lymphoma (DLBCL)
- categories
- measurements
- group Id
- BG000
- value
- 140
- title
- Ovarian
- categories
- measurements
- group Id
- BG000
- value
- 102
- title
- Prostate
- categories
- measurements
- group Id
- BG000
- value
- 85
- title
- Multiple myeloma
- categories
- measurements
- group Id
- BG000
- value
- 64
- title
- Bladder
- param Type
- NUMBER
- title
- Cancer type
- unit Of Measure
- participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 267
- title
- Breast (stage III, n=466)
- categories
- measurements
- group Id
- BG000
- value
- 194
- title
- Breast (stage IV, n=466)
- categories
- measurements
- group Id
- BG000
- value
- 101
- title
- Lung (stage III, n=345)
- categories
- measurements
- group Id
- BG000
- value
- 241
- title
- Lung (stage IV, n=345)
- categories
- measurements
- group Id
- BG000
- value
- 103
- title
- Lymphoma (DLBCL) (stage III, n=245)
- categories
- measurements
- group Id
- BG000
- value
- 135
- title
- Lymphoma (DLBCL) (stage IV, n=245)
- categories
- measurements
- group Id
- BG000
- value
- 63
- title
- Ovarian (stage III, n=140)
- categories
- measurements
- group Id
- BG000
- value
- 77
- title
- Ovarian (stage IV, n=140)
- categories
- measurements
- group Id
- BG000
- value
- 7
- title
- Prostate (stage III, n=102)
- categories
- measurements
- group Id
- BG000
- value
- 95
- title
- Prostate (stage IV, n=102)
- categories
- measurements
- group Id
- BG000
- value
- 53
- title
- Multiple myeloma (stage III, n=85)
- categories
- measurements
- group Id
- BG000
- value
- 16
- title
- Multiple myeloma (stage IV, n=85)
- description
- Table presents cancer stage by cancer stage. In addition, table presents cancer stage for all patients.
- param Type
- NUMBER
- title
- Cancer stage & type
- unit Of Measure
- participants
- population Description
- Baseline characteristics are based on the evaluable sample, e.g. all patients who received at least one dose of the study medication, had no major protocol violation and have a minimum of enrollment cycle and either one follow-up cycle or study end data with valid outcome data (i.e., ANC or completed CIN/FN data).
Complete source fields
- denoms
- counts
- group Id
- BG000
- value
- 1447
- units
- Participants
- groups
- description
- Cancer patients treated with chemotherapy and who are prescribed commercially available filgrastim biosimilar for primary or secondary prophylaxis for FN. Only patients who had no major protocol violations and have a minimum of enrollment cycle and either one follow-up cycle or study end data with valid outcome data (i.e., ANC or completed CIN/FN data) belong to the evaluable sample and are analyzed.
- id
- BG000
- title
- EP2006, Evaluable Sample
- measures
- classes
- categories
- measurements
- group Id
- BG000
- spread
- 11.8
- value
- 61.3
- dispersion Type
- STANDARD_DEVIATION
- param Type
- MEAN
- title
- Age, Continuous
- unit Of Measure
- years
- classes
- categories
- measurements
- group Id
- BG000
- value
- 886
- title
- Female
- measurements
- group Id
- BG000
- value
- 561
- title
- Male
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Sex: Female, Male
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 1042
- title
- Caucasian
- categories
- measurements
- group Id
- BG000
- value
- 7
- title
- African
- categories
- measurements
- group Id
- BG000
- value
- 2
- title
- Asian
- categories
- measurements
- group Id
- BG000
- value
- 1
- title
- Other
- categories
- measurements
- group Id
- BG000
- value
- 395
- title
- Missing
- param Type
- NUMBER
- title
- Race/Ethnicity, Customized
- unit Of Measure
- participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 395
- title
- France
- categories
- measurements
- group Id
- BG000
- value
- 143
- title
- Hungary
- categories
- measurements
- group Id
- BG000
- value
- 50
- title
- Czech Republic
- categories
- measurements
- group Id
- BG000
- value
- 116
- title
- Spain
- categories
- measurements
- group Id
- BG000
- value
- 286
- title
- Poland
- categories
- measurements
- group Id
- BG000
- value
- 3
- title
- Belgium
- categories
- measurements
- group Id
- BG000
- value
- 64
- title
- Romania
- categories
- measurements
- group Id
- BG000
- value
- 27
- title
- Austria
- categories
- measurements
- group Id
- BG000
- value
- 145
- title
- Germany
- categories
- measurements
- group Id
- BG000
- value
- 32
- title
- United Kingdom
- categories
- measurements
- group Id
- BG000
- value
- 11
- title
- Switzerland
- categories
- measurements
- group Id
- BG000
- value
- 175
- title
- Italy
- param Type
- NUMBER
- title
- Region of Enrollment
- unit Of Measure
- participants
- classes
- categories
- measurements
- group Id
- BG000
- spread
- 8.5
- value
- 165.6
- description
- Number of participants analyzed: 1358
- dispersion Type
- STANDARD_DEVIATION
- param Type
- MEAN
- title
- Height
- unit Of Measure
- cm
- classes
- categories
- measurements
- group Id
- BG000
- spread
- 15.0
- value
- 72.1
- description
- Number of participants analyzed: 1357
- dispersion Type
- STANDARD_DEVIATION
- param Type
- MEAN
- title
- Weight
- unit Of Measure
- kg
- classes
- categories
- measurements
- group Id
- BG000
- spread
- 5.0
- value
- 26.3
- description
- Number of participants analyzed: 1354
- dispersion Type
- STANDARD_DEVIATION
- param Type
- MEAN
- title
- Body-Mass Index (BMI)
- unit Of Measure
- kg/m^2
- classes
- categories
- measurements
- group Id
- BG000
- value
- 116
- title
- Bone pain
- categories
- measurements
- group Id
- BG000
- value
- 78
- title
- Joint pain
- categories
- measurements
- group Id
- BG000
- value
- 31
- title
- Muscle pain
- categories
- measurements
- group Id
- BG000
- value
- 28
- title
- Headache
- categories
- measurements
- group Id
- BG000
- value
- 8
- title
- Epistaxis
- categories
- measurements
- group Id
- BG000
- value
- 7
- title
- GI bleeding
- categories
- measurements
- group Id
- BG000
- value
- 1
- title
- Skin hemorrhage
- description
- Medical history for each patient was recorded. A patient can fall into more than one or none of the categories displayed.
- param Type
- NUMBER
- title
- Medical history
- unit Of Measure
- participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 458
- title
- Hypertension
- categories
- measurements
- group Id
- BG000
- value
- 138
- title
- Anemia
- categories
- measurements
- group Id
- BG000
- value
- 122
- title
- Diabetes Type II
- categories
- measurements
- group Id
- BG000
- value
- 93
- title
- Coronary disease
- categories
- measurements
- group Id
- BG000
- value
- 90
- title
- Allergies
- categories
- measurements
- group Id
- BG000
- value
- 86
- title
- COPD
- description
- Comorbidities for each patient were recorded. Only those comorbidities with a relative frequency of 5% or more are displayed in the table. A patient can fall into more than one or none of the categories displayed.
- param Type
- NUMBER
- title
- Comorbidities
- unit Of Measure
- participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 35
- title
- History of any repeated infection
- categories
- measurements
- group Id
- BG000
- value
- 8
- title
- Type of repeated infection (chronic)
- categories
- measurements
- group Id
- BG000
- value
- 27
- title
- Type of repeated infection (recurrent, acute)
- categories
- measurements
- group Id
- BG000
- value
- 15
- title
- 1 infectious episode in past 3 months
- categories
- measurements
- group Id
- BG000
- value
- 7
- title
- 2 infectious episodes in past 3 months
- categories
- measurements
- group Id
- BG000
- value
- 3
- title
- 3 or more infectious episodes in past 3 months
- description
- History of repeated infections for each patient was recoded. A patient can fall into more than one or none of the categories displayed.
- param Type
- NUMBER
- title
- History of repeated infections
- unit Of Measure
- participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 466
- title
- Breast
- categories
- measurements
- group Id
- BG000
- value
- 345
- title
- Lung
- categories
- measurements
- group Id
- BG000
- value
- 245
- title
- Lymphoma (DLBCL)
- categories
- measurements
- group Id
- BG000
- value
- 140
- title
- Ovarian
- categories
- measurements
- group Id
- BG000
- value
- 102
- title
- Prostate
- categories
- measurements
- group Id
- BG000
- value
- 85
- title
- Multiple myeloma
- categories
- measurements
- group Id
- BG000
- value
- 64
- title
- Bladder
- param Type
- NUMBER
- title
- Cancer type
- unit Of Measure
- participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 267
- title
- Breast (stage III, n=466)
- categories
- measurements
- group Id
- BG000
- value
- 194
- title
- Breast (stage IV, n=466)
- categories
- measurements
- group Id
- BG000
- value
- 101
- title
- Lung (stage III, n=345)
- categories
- measurements
- group Id
- BG000
- value
- 241
- title
- Lung (stage IV, n=345)
- categories
- measurements
- group Id
- BG000
- value
- 103
- title
- Lymphoma (DLBCL) (stage III, n=245)
- categories
- measurements
- group Id
- BG000
- value
- 135
- title
- Lymphoma (DLBCL) (stage IV, n=245)
- categories
- measurements
- group Id
- BG000
- value
- 63
- title
- Ovarian (stage III, n=140)
- categories
- measurements
- group Id
- BG000
- value
- 77
- title
- Ovarian (stage IV, n=140)
- categories
- measurements
- group Id
- BG000
- value
- 7
- title
- Prostate (stage III, n=102)
- categories
- measurements
- group Id
- BG000
- value
- 95
- title
- Prostate (stage IV, n=102)
- categories
- measurements
- group Id
- BG000
- value
- 53
- title
- Multiple myeloma (stage III, n=85)
- categories
- measurements
- group Id
- BG000
- value
- 16
- title
- Multiple myeloma (stage IV, n=85)
- description
- Table presents cancer stage by cancer stage. In addition, table presents cancer stage for all patients.
- param Type
- NUMBER
- title
- Cancer stage & type
- unit Of Measure
- participants
- population Description
- Baseline characteristics are based on the evaluable sample, e.g. all patients who received at least one dose of the study medication, had no major protocol violation and have a minimum of enrollment cycle and either one follow-up cycle or study end data with valid outcome data (i.e., ANC or completed CIN/FN data).
Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f
Preserved source evidence · Not medical advice
Triangle